Department of Pathology, University of California, San Francisco, CA, USA.
Cancer Biomark. 2010;9(1-6):475-91. doi: 10.3233/CBM-2011-0170.
Sarcomas are rare malignancies of mesenchymal lineage with more than 100 specific types and many benign potential mimics. In situ and precursor lesions are generally not described and thus much of molecular pathology in this field concentrates on molecular diagnosis, prognosis and determination of therapeutic targets. This chapter discusses the applications of molecular methodologies that provide insight into pathogenesis of sarcoma, and of molecular methods which are currently applied to, or will likely soon influence, the clinical management of this complex array of tumors.
肉瘤是一种罕见的间充质来源的恶性肿瘤,有超过 100 种特定类型,还有许多良性的潜在类似物。原位和前期病变通常不被描述,因此该领域的分子病理学主要集中在分子诊断、预后和治疗靶点的确定上。本章讨论了分子方法的应用,这些方法提供了对肉瘤发病机制的深入了解,以及目前应用于或可能很快影响这一复杂肿瘤群临床管理的分子方法。